129 related articles for article (PubMed ID: 15821833)
1. Hyperhomocysteinemic diabetic cardiomyopathy: oxidative stress, remodeling, and endothelial-myocyte uncoupling.
Tyagi SC; Rodriguez W; Patel AM; Roberts AM; Falcone JC; Passmore JC; Fleming JT; Joshua IG
J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):1-10. PubMed ID: 15821833
[TBL] [Abstract][Full Text] [Related]
2. Cardiac synchronous and dys-synchronous remodeling in diabetes mellitus.
Sen U; Tyagi N; Moshal KS; Kartha GK; Rosenberger D; Henderson BC; Joshua IG; Tyagi SC
Antioxid Redox Signal; 2007 Jul; 9(7):971-8. PubMed ID: 17508918
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model.
Tyagi N; Moshal KS; Lominadze D; Ovechkin AV; Tyagi SC
Can J Physiol Pharmacol; 2005 Jul; 83(7):583-94. PubMed ID: 16091784
[TBL] [Abstract][Full Text] [Related]
4. Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
Mishra PK; Tyagi N; Sen U; Joshua IG; Tyagi SC
Cardiovasc Diabetol; 2010 Sep; 9():49. PubMed ID: 20828387
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide in matrix remodeling in diabetes and heart failure.
Tyagi SC; Hayden MR
Heart Fail Rev; 2003 Jan; 8(1):23-8. PubMed ID: 12652156
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.
Rosenberger D; Moshal KS; Kartha GK; Tyagi N; Sen U; Lominadze D; Maldonado C; Roberts AM; Tyagi SC
Arch Physiol Biochem; 2006; 112(4-5):219-27. PubMed ID: 17178594
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?
Sen U; Tyagi SC
PPAR Res; 2010; 2010():806538. PubMed ID: 20613990
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.
Moshal KS; Tyagi N; Henderson B; Ovechkin AV; Tyagi SC
Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2770-7. PubMed ID: 15681708
[TBL] [Abstract][Full Text] [Related]
9. PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice.
Rodriguez WE; Sen U; Tyagi N; Kumar M; Carneal G; Aggrawal D; Newsome J; Tyagi SC
Int J Biol Sci; 2008 Aug; 4(4):236-44. PubMed ID: 18690293
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia.
Moshal KS; Metreveli N; Frank I; Tyagi SC
Curr Vasc Pharmacol; 2008 Apr; 6(2):84-92. PubMed ID: 18393909
[TBL] [Abstract][Full Text] [Related]
11. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia.
Sood HS; Hunt MJ; Tyagi SC
Am J Physiol Lung Cell Mol Physiol; 2003 Feb; 284(2):L333-41. PubMed ID: 12533311
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K
Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine in microvascular endothelial cell barrier permeability.
Tyagi SC; Lominadze D; Roberts AM
Cell Biochem Biophys; 2005; 43(1):37-44. PubMed ID: 16043881
[TBL] [Abstract][Full Text] [Related]
15. Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.
Tyagi N; Qipshidze N; Sen U; Rodriguez W; Ovechkin A; Tyagi SC
Int J Physiol Pathophysiol Pharmacol; 2011 Sep; 3(3):210-22. PubMed ID: 21941612
[TBL] [Abstract][Full Text] [Related]
16. Ciglitazone ameliorates homocysteine-mediated mitochondrial translocation and matrix metalloproteinase-9 activation in endothelial cells by inducing peroxisome proliferator activated receptor-gamma activity.
Tyagi N; Moshal KS; Sen U; Lominadze D; Ovechkin AV; Tyagi SC
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(5):21-7. PubMed ID: 17543202
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.
Farhangkhoee H; Khan ZA; Kaur H; Xin X; Chen S; Chakrabarti S
Pharmacol Ther; 2006 Aug; 111(2):384-99. PubMed ID: 16343639
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine-Induced Endothelial Dysfunction.
Lai WK; Kan MY
Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction in diabetes mellitus.
Cosentino F; Lüscher TF
J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S54-61. PubMed ID: 9883749
[TBL] [Abstract][Full Text] [Related]
20. Generation of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats.
Sood HS; Cox MJ; Tyagi SC
Antioxid Redox Signal; 2002 Oct; 4(5):799-804. PubMed ID: 12470508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
